mfine is a technology company.
mfine has raised $82.0M across 3 funding rounds.
mfine has raised $82.0M in total across 3 funding rounds.
mfine has raised $82.0M in total across 3 funding rounds.
mfine's investors include BEENEXT, SBI Ven Capital, Matrix Partners India, Tiger Global Management.
MFine is an AI-driven, on-demand digital healthcare platform based in Bengaluru, India, founded in 2017, that connects users with top doctors for virtual consultations via chat or video, alongside services like lab tests, medicine delivery, radiology bookings, and comprehensive health packages.[1][2][4][5] It serves patients seeking convenient access to quality care—especially in rural areas—corporate clients, and insurance users, solving key problems like geographical barriers, long wait times, and fragmented healthcare by integrating diagnostics, continuous monitoring, and cashless claims into a seamless app experience.[1][2][3][4] With $118.82M raised and a merger with LifeCell in July 2022, MFine has scaled to partner with 500+ hospitals, 4,000+ doctors, and 500+ NABL labs, serving over 1L+ patients while emphasizing data security and AI for personalized care.[1][4]
MFine was founded in December 2017 by Ashutosh Lawania and Prasad Kompalli, later joined by Ajit Narayanan and Arjun Choudhary, driven by the conviction that AI and mobile adoption could transform healthcare access in India.[4][5] The idea emerged to address gaps in timely, quality care amid complex, unreliable services, focusing on an integrated platform for illness-recovery and wellness journeys rather than siloed tools.[4] Early traction came from partnering with top hospitals instead of individual doctors, enabling instant consultations and at-home services; pivotal moments include COVID-19 innovations like mobile screening and cough sound analysis via app partnerships in Hyderabad, plus patented tech for vitals tracking without hardware.[4][7]
MFine rides the telemedicine and digital health wave in India, fueled by massive mobile penetration, rising health insurance adoption, and post-COVID demand for contactless care, positioning it amid competitors like Practo, 1mg, and Doxiva in a market shifting toward integrated platforms.[1][4] Timing aligns with regulatory pushes for digitized health records and AI in diagnostics, amplified by rural-urban divides where physical access lags; market forces like corporate wellness programs and insurance integration favor its B2B2C model.[2][4] It influences the ecosystem by setting standards for AI-enhanced, hospital-partnered telehealth, enabling preventive care scalability and data unification, which accelerates broader adoption of on-demand healthcare.[3][7]
MFine's post-merger trajectory points to expanded connected care, deeper insurance and corporate integrations, and AI advancements in predictive health tracking amid India's booming digital health sector. Trends like widespread UPI health wallets, wearable synergies, and rural telehealth mandates will propel growth, potentially evolving its influence toward a full-stack primary care leader. This builds on its foundational mission, delivering fingertip-quality care to millions.[2][4]
mfine has raised $82.0M across 3 funding rounds. Most recently, it raised $49.0M Series C in August 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 1, 2021 | $49.0M Series C | BEENEXT, SBI Ven Capital | |
| Jan 1, 2021 | $16.0M Venture Round | BEENEXT, Matrix Partners India, SBI Ven Capital, Tiger Global Management | |
| Apr 1, 2019 | $17.0M Series B | BEENEXT, Matrix Partners India, SBI Ven Capital, Tiger Global Management |